Literature DB >> 25262369

The effects of dose reduction of furosemide on glomerular filtration rate in stable systolic heart failure.

Paul M McKie, John A Schirger, Sherry L Benike, Lynn K Harstad, Horng H Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25262369      PMCID： PMC4467558          DOI： 10.1016/j.jchf.2014.05.014

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  5 in total

1.  Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.

Authors:  Horng H Chen; Margaret M Redfield; Linda J Nordstrom; Alessandro Cataliotti; John C Burnett
Journal:  Am J Physiol Renal Physiol       Date:  2003-05

2.  Mechanism of the effects of furosemide on renin secretion in anesthetized dogs.

Authors:  A J Vander; J Carlson
Journal:  Circ Res       Date:  1969-08       Impact factor: 17.367

3.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

Authors:  D L Dries; D V Exner; M J Domanski; B Greenberg; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

4.  Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

Authors:  Michael Domanski; James Norman; Bertram Pitt; Mark Haigney; Stephen Hanlon; Eliot Peyster
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

5.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690
  5 in total
  5 in total

1.  Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial.

Authors:  Rajiv Agarwal; Andrew E Cramer; Mary Balmes-Fenwick; Arjun D Sinha; Fangqian Ouyang; Wanzhu Tu
Journal:  Am J Nephrol       Date:  2020-07-14       Impact factor: 3.754

Review 2.  Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Cicoira Maria Antonietta; Emiliano Calvi; Andrea Faggiano; Caterina Maffeis; Marco Bosisio; Marco De Stefano; Stefano Carugo; Pompilio Faggiano
Journal:  Curr Heart Fail Rep       Date:  2022-01-17

3.  Clinical predictors of hyponatremia in patients with heart failure according to severity of chronic kidney disease.

Authors:  Ivan Velat; Željko Bušić; Viktor Čulić
Journal:  Wien Klin Wochenschr       Date:  2022-05-17       Impact factor: 2.275

Review 4.  Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients.

Authors:  Chris J Kapelios; Μaria Bonou; Konstantinos Malliaras; Eleni Athanasiadi; Styliani Vakrou; Marina Skouloudi; Constantina Masoura; John Barbetseas
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

5.  Furosemide and spironolactone doses and hyponatremia in patients with heart failure.

Authors:  Ivan Velat; Željko Bušić; Marina Jurić Paić; Viktor Čulić
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-03       Impact factor: 2.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.